Kidney Failure, Chronic
|
0.070 |
Biomarker
|
disease |
BEFREE |
We evaluated this kit's removal abilities of uremic toxins such as urea, creatinine, uric acid, phosphorus, and β2-microglobulin from the dialysate of end-stage renal disease (ESRD) patients in vitro.
|
30678941 |
2019 |
Kidney Failure, Chronic
|
0.070 |
PosttranslationalModification
|
disease |
BEFREE |
In addition to LTB<sub>4</sub> and TXA<sub>2</sub>, it is also suggested that β2-microglobulin and interleukin-31 are involved in itching associated with CRF-induced pruritus.
|
30659825 |
2019 |
Kidney Failure, Chronic
|
0.070 |
AlteredExpression
|
disease |
BEFREE |
BUN, Scr, serum phosphorus, intact parathyroid hormone (iPTH), fibrinogen, and β2-microglobulin (β2-MG) decreased while hemoglobin, albumin, and activated partial thromboplastin time increased in the patients suffering ESRD; patients presented with improvements in subjective symptoms and an increase in dry weight.
|
30320415 |
2019 |
Kidney Failure, Chronic
|
0.070 |
Biomarker
|
disease |
BEFREE |
However, this syndrome can also be observed in end-stage renal diseases (ESRD) patients undergoing peritoneal dialysis, and even in patients with chronic renal failure before the initiation of dialytic therapy, suggesting that HD is not a direct cause but that accumulation of β2M or some β2M-associated molecules in the body is a common pathogenesis.
|
29896815 |
2018 |
Kidney Failure, Chronic
|
0.070 |
Biomarker
|
disease |
BEFREE |
In this paper, we revisit the role of beta-2 microglobulin (β<sub>2</sub>M) as a biomarker in patients with chronic kidney disease and end-stage renal disease.
|
28664159 |
2017 |
Kidney Failure, Chronic
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
In the Atherosclerosis Risk in Communities Study (n = 13,277 from 4 US communities), we used structural equation modeling to estimate the association between serum 1,5-AG levels and end-stage renal disease (ESRD) from baseline (1990-1992) through 2013 with adjustment for demographics, risk factors, a latent variable for glycemia (diabetes status, fasting glucose, glycated hemoglobin (HbA1c), fructosamine, glycated albumin), and a latent variable for kidney function (creatinine, cystatin C, β2-microglobulin).
|
28535187 |
2017 |
Kidney Failure, Chronic
|
0.070 |
Biomarker
|
disease |
BEFREE |
Dialysis-related amyloidosis as represented by carpal tunnel syndrome is a serious complication of long-term dialysis treatment of patients with chronic renal failure. beta 2-microglobulin has been identified as a structural component of the amyloid deposits, but other factors also are associated with amyloid formation.
|
9350687 |
1997 |